Vir Biotechnology (VIR) Non-Current Assets (2018 - 2026)
Vir Biotechnology (VIR) posted Non-Current Assets of $603.58 million for Q3 2026, up 27.4% from $473.77 million a year earlier but down 5.8% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Vir Biotechnology's Non-Current Assets came in at $488.74 million, up 37.2% from FY2024.
- Annual Non-Current Assets has increased for three consecutive years, with a five-year compound annual growth rate of 27.3% (FY2020 to FY2025).
- In prior years, Vir Biotechnology's Non-Current Assets was $356.36 million in FY2024 (+7.7%), $330.83 million in FY2023 (+16.9%), $283.01 million in FY2022 (-27.7%) and $391.45 million in FY2021 (+167.4%).
- Quarterly Non-Current Assets has run from a low of $275.72 million in Q3 2023 to a high of $641.07 million in Q2 2026 over five years.
- On a year-over-year basis, Non-Current Assets has increased in each of the last five quarters, with growth averaging 14.3% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2021, with growth of 167.4%; the weakest was Q1 2025, with a decline of 35.4%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $641.07 million (Q2 2026), $502.6 million (Q1 2026) and $488.74 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Vir Biotechnology | 2.28 Bn | 363.84 Mn | 188,000.00 | 603.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 603.58 Mn |
| Jun 30, 2026 | 641.07 Mn |
| Mar 31, 2026 | 502.60 Mn |
| Dec 31, 2025 | 488.74 Mn |
| Sep 30, 2025 | 473.77 Mn |
| Jun 30, 2025 | 456.83 Mn |
| Mar 31, 2025 | 375.52 Mn |
| Dec 31, 2024 | 356.36 Mn |
| Sep 30, 2024 | 451.20 Mn |
| Jun 30, 2024 | 463.82 Mn |
| Mar 31, 2024 | 580.87 Mn |
| Dec 31, 2023 | 330.83 Mn |
| Sep 30, 2023 | 275.72 Mn |
| Jun 30, 2023 | 297.54 Mn |
| Mar 31, 2023 | 307.30 Mn |
| Dec 31, 2022 | 283.01 Mn |
| Sep 30, 2022 | 282.35 Mn |
| Jun 30, 2022 | 330.73 Mn |
| Mar 31, 2022 | 319.58 Mn |
| Dec 31, 2021 | 391.45 Mn |
API Access
Vir Biotechnology Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();